These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6362932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HLA and leprosy in the pre and postgenomic eras.
    Geluk A, Ottenhoff TH.
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
    Van Schooten WC, Elferink DG, Van Embden J, Anderson DC, De Vries RR.
    Eur J Immunol; 1989 Nov; 19(11):2075-9. PubMed ID: 2480902
    [Abstract] [Full Text] [Related]

  • 8. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, Pattengale PK, Bloom BR.
    Nature; 1989 Nov; 322(6078):459-61. PubMed ID: 2942780
    [Abstract] [Full Text] [Related]

  • 9. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 10. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
    Mutis T, van Schooten WC, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):788-93. PubMed ID: 2681461
    [Abstract] [Full Text] [Related]

  • 11. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S, Ramanathan S, Shankernarayan N, Ramu G, Muthukkarauppan V.
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [Abstract] [Full Text] [Related]

  • 12. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 13. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N, Gelber RR, Engleman EG.
    J Immunol; 1987 Jan 15; 138(2):570-4. PubMed ID: 2947952
    [Abstract] [Full Text] [Related]

  • 14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 15. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 16. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue.
    Kim J, Sette A, Rodda S, Southwood S, Sieling PA, Mehra V, Ohmen JD, Oliveros J, Appella E, Higashimoto Y, Rea TH, Bloom BR, Modlin RL.
    J Immunol; 1997 Jul 01; 159(1):335-43. PubMed ID: 9200471
    [Abstract] [Full Text] [Related]

  • 17. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
    Toews GB, Vial WC, Dunn MM, Guzzetta P, Nunez G, Stastny P, Lipscomb MF.
    J Immunol; 1984 Jan 01; 132(1):181-6. PubMed ID: 6228577
    [Abstract] [Full Text] [Related]

  • 18. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae.
    Harris DP, Jones AG, Wade S, Krahenbuhl JL, Gillis TP, Watson JD.
    J Immunol; 1988 Sep 01; 141(5):1695-700. PubMed ID: 2970509
    [Abstract] [Full Text] [Related]

  • 19. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH.
    Clin Vaccine Immunol; 2008 Mar 01; 15(3):522-33. PubMed ID: 18199740
    [Abstract] [Full Text] [Related]

  • 20. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE, Janson AA, Kifle A, Howe RC, McLean K, Nurilygn A, Filley E, Shannon EJ, Bulla GJ, Hermans J.
    Int J Lepr Other Mycobact Dis; 1995 Sep 01; 63(3):369-80. PubMed ID: 7594920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.